Genome-wide Alteration of 5-Hydroxymenthylcytosine in a Mouse Model of Alzheimer’s Disease

Liqi Shu,Wenjia Sun,Liping Li,Zihui Xu,Li Lin,Pei Xie,Hui Shen,Luoxiu Huang,Qi Xu,Peng Jin,Xuekun Li
DOI: https://doi.org/10.1186/s12864-016-2731-1
IF: 4.547
2016-01-01
BMC Genomics
Abstract:Alzheimer’s disease (AD) is the most common form of neurodegenerative disorder that leads to a decline in cognitive function. In AD, aggregates of amyloid β peptide precede the accumulation of neurofibrillary tangles, both of which are hallmarks of the disease. The great majority (>90 %) of the AD cases are not originated from genetic defects, therefore supporting the central roles of epigenetic modifications that are acquired progressively during the life span. Strong evidences have indicated the implication of epigenetic modifications, including histone modification and DNA methylation, in AD. Recent studies revealed that 5-hydroxymethylcytosine (5hmC) is dynamically regulated during neurodevelopment and aging.
What problem does this paper attempt to address?